<qa>  To evaluate the proportion of patients with objective response rate ORR to the combination treatment ofI. To evaluate the proportion of patients with objective response rate ORR according to Response Evaluation Criteria in Solid Tumors RECIST criteria to the combination treatment of nivolumab with Y-90. 